Creatine Kinase Test: Indications and Interpretation
Total CK should not be used for diagnosing myocardial infarction—cardiac troponin is the preferred biomarker, with CK-MB mass assay as an acceptable alternative only when troponin is unavailable. 1
Primary Indications for CK Testing
For Suspected Myocardial Injury (Limited Role)
- Do NOT order total CK for cardiac evaluation 1
- Total CK has poor specificity due to high skeletal muscle concentration and should no longer be used for MI diagnosis 1
- If CK-MB is used (when troponin unavailable):
For Suspected Neuromuscular Disorders (Primary Role)
- Evaluate muscle weakness, myalgia, or suspected myopathy 2, 3
- Monitor checkpoint inhibitor-related myositis 4
Interpretation Framework
Normal Reference Ranges Vary Significantly by Demographics 5
Critical caveat: Standard laboratory cutoffs fail to account for race and sex differences
97.5th Percentile Values:
- White men: 382 IU/L
- Black men: 1001 IU/L
- White women: 295 IU/L
- Black women: 487 IU/L
Additional factors increasing baseline CK:
- Male sex (consistently higher) 5, 6
- Black race (5-8 fold higher odds of "abnormal" by standard cutoffs) 5
- Increased muscle mass, athletes 6
- Younger age in men 5
- Obesity in men (2-fold increased odds) 5
Diagnostic Thresholds for Myopathy 7
Laboratory-defined cutoffs:
- Sensitivity: 77%, Specificity: 67%, PPV: 87% for neuromuscular disorders
CK >1000 IU/L:
- Highly predictive of inflammatory myopathy or neuromuscular disorder 7
European Federation of Neurological Societies thresholds:
- Marginally better specificity (78%) than standard cutoffs 7
Clinical Interpretation Patterns
Elevated CK with muscle symptoms:
- Correlates with disease severity, necrosis extent, and available muscle mass 6
- Serial measurements more informative than single values
- Consider inflammatory myopathy, muscular dystrophy, metabolic myopathy, drug-induced (statins)
Elevated CK without symptoms (Idiopathic HyperCKemia):
- Requires: asymptomatic patient, negative family history, normal neurological exam, normal EMG, normal muscle biopsy 6
- Often reflects demographic variation rather than pathology 5
Normal/minimally elevated CK does NOT exclude myopathy:
- Some myopathies present with normal CK 3
- Consider alternative testing (troponin, aldolase, myositis antibodies, EMG, MRI, biopsy)
CK elevation in neurogenic disorders:
- Can occur in Kennedy's disease, type III spinal muscular atrophy 6
- Degree of elevation typically less than primary myopathies
Common Pitfalls to Avoid
- Using total CK for cardiac diagnosis - explicitly contraindicated 1
- Ignoring demographic factors - Black patients have 5-8x higher baseline CK; using standard cutoffs leads to false positives 5
- Single measurement interpretation - serial testing demonstrates rise/fall pattern critical for acute events 1
- Assuming normal CK excludes myopathy - many myopathies have normal or minimally elevated CK 3
- Ordering CK when troponin available - troponin superior for cardiac injury detection 1